951a – Budesonide Orodispersible Tablets are Highly Effective to Maintain Clinico-Histological Remission in Adult Patients with Eosinophilic Esophagitis: Results from the 48-Weeks, Double-Blind, Placebo-Controlled, Pivotal Eos-2 Trial
Alfredo J. Lucendo(Hospital General de Tomelloso), Alex Straumann(University of Zurich), Ahmed Madisch(Technische Universität Dresden), Alain Schoepfer(University Hospital of Lausanne), Ralph Müeller(Dr Falk Pharma (Germany)), Michael Vieth(Bayreuth Medical Center), Petr Hrúz, Stefan Schubert, Ulrike von Arnim, Albert J. Bredenoord(Amsterdam Neuroscience), Luc Biedermann(University of Zurich), Dirk Hartmann, Christoph Schlag, Stephan Miehlke(University Medical Center Hamburg-Eppendorf), Roland Greinwald(Dr Falk Pharma (Germany)), Constanza Ciriza de los Ríos(Hospital Clínico San Carlos), Jamal Hayat, Stephen E. Attwood(Durham University), Cecílio Santander
Cited by 10
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
|Allergy|2014|1.4k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Esophageal eosinophilia with dysphagia
|Digestive Diseases and Sciences|1993|889
Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia
|New England Journal of Medicine|2019|517